Jennifer Fuller, PhD
Director of Research
Dr. Fuller has over 20 years of experience in the biosciences including urokinase in host-pathogen interactions, stem cell homing and hematopoiesis (at the University of Michigan), HIV vaccine development (at NYU School of Medicine) and the genomic basis of diseases including diabetes and COPD (at Weill Cornell Medical College). Dr. Fuller is currently Principal Investigator of an NIH SBIR Phase II grant, which funds the development of HistoReceptomics technologies at GeneCentrix. She has previously held NIH-specified leadership roles, including co-director of an NIH T32 training program and Director of a Core within an NIH-funded program project (P50) award. She earned her BS from Michigan State University, her MA from New York University and her PhD in Immunology from the University of Michigan.
Peter Weinberg, PhD
Senior Data Scientist
Dr. Weinberg has been leading data science projects at GeneCentrix since 2019. Prior to joining GeneCentrix, he worked as a data scientist and analyst in multiple industries, including biopharma, the music industry, data warehousing and political consulting. Dr. Weinberg received a PhD in genetics and neural development from Columbia University, where he specialized in the genetic mechanisms regulating neuronal differentiation, guidance, and synaptic partner choice.
David Sasson, MS
Mr. Sasson is an applied data scientist at GeneCentrix. He graduated from Macaulay Honors College with a degree in biochemistry and a graduate degree in Health Data Science from Harvard University. Previously, he has conducted research at Argonne National Laboratory and MIT's Computational Physiology group.
Anmol Gorakshakar, MS
Mr. Gorakshakar has a Master’s degree in Biotechnology at NYU Tandon School of Engineering and has a previous Masters in Biotechnology Degree from VIT University, India. Prior to joining GeneCentrix, he worked in Fundamental as well as Applied Biology as a Research Assistant in various research organizations, including NYU Dentistry.
Mr. Talantikite has more than 10 years of experience as a full stack software engineer at numerous Silicon Valley tech companies. He has worked at rapid-growth startups as well as large tech innovators, such as Apple. An expert in cloud technologies, he was an early engineer at cloud Engine Yard, the first cloud PaaS. He continues to advise startups while designing and building scalable software systems. Mr. Talantikite graduated from the University of Massachusetts, Amherst, with a combined degree in Mathematics and Economics.
CEO and COO
Mr. Cardozo is a graduate of the University of Massachusetts-Amherst Commonwealth Honors College with an interdisciplinary bachelor’s degree. Mr. Cardozo has 12 years of experience in pre-award, post-award, finance and compliance administration at NYU School of Medicine and GeneCentrix, and over 18 years’ experience in small business administration and non-profits.
Ms. Kornberg as more than 10 years' experience in digital marketing. Previously a journalist, she has more recently worked for an online advertising agency, a digital communications company, and several non-profit organizations. Her clients have included Google, Canon, Pearson Education, the Business-Higher Education Forum, and Virunga National Park. She received a BA in English from Amherst College.
Consultant (Software Development)
Timothy Cardozo, MD-PhD
Co-Founder and Chairman of Advisory Board
Dr. Cardozo has 20 years experience in informatics and drug discovery and has extensive industry contacts. He has won DP2 and DP1 NIH innovation awards, and has been awarded 6 patents in the space. Dr. Cardozo is currently an Associate Professor of Biochemistry and Pharmacology at NYU Langone Health (NYULH) and has initiated over 20 drug discovery and protein engineering collaborations within NYULH.
Ritu Goyanka, PhD
Dr. Goyanka is the founder of RG Advisors and Consultants, LLC. She works with small biotech companies, startups and foundations to provide secondary research, due diligence, IP management, evaluating technologies for commercial potential, market intelligence and competitive analysis reports as well as to identify potential partners for commercialization. She has a Ph.D. from NYU School of Medicine where her research was focused on protein design and rational drug discovery.
Rahul Satija, PhD
Dr. Satija is an NIH-funded, principal investigator at the New York Genome Center. with a joint appointment as Assistant Professor at the Center for Genomics and Systems Biology at New York University (NYU). Prior to joining the NYGC, Dr. Satija was a postdoctoral researcher at the Broad Institute of Harvard and MIT, where he developed new methods for single cell analysis.
Klara Felsovalyi, PhD
Research Director (ex officio) is a computational biologist who received her PhD from Columbia University in the Laboratory of Dr. Barry Honig, a leading computational biologist and chemist. Dr. Felsovalyi currently works for Richter Gedeon, Hungary’s largest pharmaceutical company.
Marisa Tricarico, MBA
Ms. Tricarico is a healthcare venture expert, formerly of the NYU Innovation Venture Fund Lux Capital, the New York Angels, and Agoranov, one of Paris' leading startup incubators. She has also been an Associate at Clarion Healthcare, a strategy consulting firm. She holds a B.A. in Cognitive Neuroscience from Boston University, an MBA from New York University, and an MBA from HEC, Paris.
Lea Lough, PhD
Dr. Lough was a member of the GeneCentrix scientific team from 2018-2020. She received her BS and MS from San Francisco State University in chemistry with a concentration in biochemistry. Dr. Lough went on to complete her PhD at the NYU Sackler Graduate School where she specialized in small molecule drug discovery. During her postdoctoral training, Dr. Lough investigated biomarkers associated with Alzheimer’s Disease and cardiovascular disease.
Mr. Ni has 10 years’ experience in cheminformatics, software development, systems administration and data science at New York University, NYU School of Medicine and GeneCentrix. Mr. Ni earned a B.A. in Chemistry with a minor in Computer Science at NYU.
Consultant, CEO Emeritus
Ms. Tivon is a graduate of New York University with a B.A. in Biochemistry. Formerly a lab and project manager at NYU School of Medicine, she is currently completing her MBA at USC Marshall. Ms. Tivon was CEO of GeneCentrix from its founding in 2014 to 2019.
Lauren M. Young, MD-PhD
Dr. Young is a molecular cell biology and genomics expert who was PI of one of GeneCentrix’ Phase I NIH awards. Dr. Young has worked in the biosciences for over fifteen years. She earned her B.A. in History and Science at Harvard University and her M.D. and Ph.D. degrees from NYU School of Medicine.